Cocaine use, hypertension, and end-stage renal disease

K C Norris1, M Thornhill-Joynes, C Robinson

  • 1Department of Medicine, Charles R. Drew University of Medicine and Science, Los Angeles, CA 90059, USA. knorris@ucla.edu

Insights

Cocaine use is strongly linked to hypertension-related end-stage renal disease (HTN-ESRD) in urban dialysis patients. Cocaine users developed HTN-ESRD earlier and should be considered a cause of renal failure.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Toxicology

Background:

  • Cocaine use is linked to acute kidney injury and hypertension (HTN).
  • Emerging data suggest cocaine may cause chronic kidney disease.
  • Hypertension-related end-stage renal disease (HTN-ESRD) is a significant health concern.

Purpose of the Study:

  • To investigate the association between cocaine use and HTN-ESRD in hemodialysis patients.
  • To compare the prevalence of HTN-ESRD in cocaine users versus non-users.
  • To identify characteristics of HTN-ESRD patients with a history of cocaine use.

Main Methods:

  • Cross-sectional study design.
  • Evaluation of 193 Black patients from urban hemodialysis units.
  • Data collection on cocaine use history and HTN-ESRD diagnosis.

Main Results:

  • 28.5% of patients reported significant cocaine use before dialysis.
  • Cocaine users had a significantly higher prevalence of HTN-ESRD (89.1% vs. 46.4%).
  • Cocaine users with HTN-ESRD were younger and had a shorter duration of HTN.

Conclusions:

  • A history of cocaine use is strongly associated with HTN-ESRD in this urban dialysis population.
  • Cocaine use is linked to an earlier onset of end-stage renal disease (ESRD).
  • Cocaine should be considered a potential cause of ESRD, especially in patients lacking a clear etiology.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...